After the initial month of plaster use, the reported pain relief showed a median improvement of 30% across all patients, while current users experienced a higher median relief of 50%. These levels of pain relief were sustained at the time of the survey, indicating consistent effectiveness over the observed period. The data suggests that plaster use provides meaningful pain relief, with current users benefiting more significantly.
Key Points Explained:
-
Median Pain Relief for All Patients:
- The median pain relief reported after the first month of plaster use was 30% for all patients. This indicates that half of the patients experienced at least a 30% reduction in pain, while the other half had varying levels of relief, some higher and some lower.
- This figure remained stable at the time of the survey, suggesting that the plaster's effectiveness did not diminish over time for the general patient population.
-
Median Pain Relief for Current Users:
- Current users of the plaster reported a higher median pain relief of 50% after the initial month. This suggests that those who continued using the plaster experienced significantly better outcomes compared to the broader patient group.
- Like the overall group, this 50% relief level was maintained at the time of the survey, highlighting the plaster's sustained efficacy for ongoing users.
-
Implications for Purchasers:
- The data underscores the importance of adherence to plaster use, as current users saw a 20% greater median pain relief compared to the general patient population.
- For healthcare providers or purchasers, this suggests that encouraging consistent use could enhance patient outcomes. The plaster's sustained effectiveness also supports its reliability as a pain management tool over time.
-
Considerations for Future Use:
- Have you considered how patient compliance might influence the effectiveness of plaster use in your setting? The disparity between all patients and current users highlights the potential impact of adherence on outcomes.
- The stability of pain relief over time suggests that the plaster could be a viable long-term option for managing pain, particularly for patients who remain committed to its use.
These findings quietly underscore the role of consistent medical interventions in shaping effective pain management strategies.
Summary Table:
Patient Group | Median Pain Relief (1 Month) | Sustained Relief? |
---|---|---|
All Patients | 30% | Yes |
Current Users | 50% | Yes |
Enhance patient outcomes with reliable pain relief solutions!
At Enokon, we specialize in manufacturing high-quality transdermal patches and pain plasters designed for lasting effectiveness. Our products deliver consistent pain relief, as evidenced by the 30-50% median improvement reported in clinical surveys.
Why choose Enokon?
✔ Bulk manufacturing expertise – Ideal for healthcare distributors & brands
✔ Custom R&D support – Tailored formulations for your needs
✔ Proven adherence benefits – Higher relief rates for ongoing users
Let’s discuss how our plasters can improve pain management in your practice. Contact our team today for bulk orders or custom solutions!